U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Acquired by HighTower Advisors LLC

HighTower Advisors LLC lifted its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 13.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,714 shares of the company’s stock after purchasing an additional 566 shares during the quarter. HighTower Advisors LLC’s holdings in U.S. Physical Therapy were worth $399,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Canada Pension Plan Investment Board acquired a new position in U.S. Physical Therapy during the 2nd quarter valued at approximately $28,000. Innealta Capital LLC purchased a new stake in shares of U.S. Physical Therapy during the second quarter valued at $30,000. Quest Partners LLC increased its position in shares of U.S. Physical Therapy by 2,808.3% in the 2nd quarter. Quest Partners LLC now owns 349 shares of the company’s stock valued at $32,000 after acquiring an additional 337 shares during the period. Quarry LP raised its stake in U.S. Physical Therapy by 1,291.9% in the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after acquiring an additional 478 shares during the last quarter. Finally, Ridgewood Investments LLC purchased a new position in U.S. Physical Therapy in the 2nd quarter worth $51,000.

Insiders Place Their Bets

In other news, CFO Carey P. Hendrickson sold 516 shares of the business’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the completion of the sale, the chief financial officer now directly owns 20,469 shares in the company, valued at $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Eric Joseph Williams sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $95.84, for a total value of $191,680.00. Following the transaction, the insider now directly owns 14,814 shares of the company’s stock, valued at approximately $1,419,773.76. The trade was a 11.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 7,412 shares of company stock worth $706,605. Company insiders own 1.70% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their price target for the company from $100.00 to $115.00 in a research note on Monday, December 16th. JPMorgan Chase & Co. increased their price target on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd. Barrington Research reissued an “outperform” rating and set a $108.00 price target on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. Finally, JMP Securities began coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They set an “outperform” rating and a $113.00 target price for the company. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $114.00.

U.S. Physical Therapy Trading Down 0.1 %

U.S. Physical Therapy stock opened at $91.31 on Monday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The firm has a market cap of $1.38 billion, a PE ratio of 97.14, a P/E/G ratio of 4.23 and a beta of 1.46. The stock’s 50 day simple moving average is $90.80 and its two-hundred day simple moving average is $89.73. U.S. Physical Therapy, Inc. has a 12 month low of $76.18 and a 12 month high of $113.63.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 15th were issued a $0.44 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a yield of 1.93%. U.S. Physical Therapy’s payout ratio is 187.23%.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.